Hi,here's what I think is a fair question for those of you with...

Hi,

here's what I think is a fair question for those of you with good insight into AVX.
First a quick summary from watching it over the past year:

1. The product works.
2. They're in Phase 3.
3. Most bios at this stage would go into production eventually.
But..
4. The FDA required extra trials
5. The company does not have enough money to complete them.

My question is:

Why hasn't the Managing Director managed to get a partner aboard to pay for the rest?
If his product is so great it should not be difficult.
Is it that he is not a good MD, and should be replaced?

AVX is a very exciting bio, but I am worried about it on a corporate rather than scientific level. Hopefully someone can provide some insight,

Joel